These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3061675)

  • 21. Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates.
    Henry M; Diallo I; Bordes J; Ka S; Pradines B; Diatta B; M'Baye PS; Sane M; Thiam M; Gueye PM; Wade B; Touze JE; Debonne JM; Rogier C; Fusai T
    Am J Trop Med Hyg; 2006 Jul; 75(1):146-51. PubMed ID: 16837722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A review of present antimalaria activities in Africa.
    Beausoleil EG
    Bull World Health Organ; 1984; 62 Suppl(Suppl):13-7. PubMed ID: 6397273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-treatment with chloroquine and parasite chloroquine resistance in Ghanaian children with severe malaria.
    Evans JA; May J; Tominski D; Eggelte T; Marks F; Abruquah HH; Meyer CG; Timmann C; Agbenyega T; Horstmann RD
    QJM; 2005 Nov; 98(11):789-96. PubMed ID: 16186171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of malaria chemoprophylaxis in Africa with special reference to Madagascar, Cameroon, and Senegal.
    Laing AB
    Bull World Health Organ; 1984; 62 Suppl(Suppl):41-8. PubMed ID: 6397276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parasitological and clinical efficacy of standard treatment regimens against Plasmodium falciparum, P. vivax and P. malariae in Papua New Guinea.
    Genton B; Baea K; Lorry K; Ginny M; Wines B; Alpers MP
    P N G Med J; 2005; 48(3-4):141-50. PubMed ID: 17212060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antimalarial drugs and their ways to use in the African milieu.
    Zoguéreh DD; Delmont J
    Sante; 2000; 10(6):425-33. PubMed ID: 11226940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in-vivo study of falciparum malaria sensitivity to Chloroquine in unstable malaria endemic area of central Ethiopia.
    Kebede F; Taffa N; Tedla T
    Ethiop Med J; 1999 Apr; 37(2):97-109. PubMed ID: 11957310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failure of a chloroquine chemoprophylaxis program to adequately prevent malaria during pregnancy in Koupéla District, Burkina Faso.
    Sirima SB; Sawadogo R; Moran AC; Konate A; Diarra A; Yameogo M; Parise ME; Newman RD
    Clin Infect Dis; 2003 Jun; 36(11):1374-82. PubMed ID: 12766831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A quantitative approach to recommendations on malaria prophylaxis.
    Pappaioanou M; Lobel HO; Campbell CC
    Bull World Health Organ; 1988; 66(4):477-84. PubMed ID: 3048761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent applied field research activities carried out in tropical Africa.
    Goriup S; van der Kaay HJ
    Bull World Health Organ; 1984; 62 Suppl(Suppl):31-9. PubMed ID: 6397275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From the Centers for Disease Control. Recommendations for the prevention of malaria among travelers.
    JAMA; 1990 May 23-30; 263(20):2729, 2734, 2737 passim. PubMed ID: 2159078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recommendations for the prevention of malaria among travelers.
    MMWR Recomm Rep; 1990 Mar; 39(RR-3):1-10. PubMed ID: 2156146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antenatal chloroquine chemoprophylaxis in Malawi: chloroquine resistance, compliance, protective efficacy and cost.
    Heymann DL; Steketee RW; Wirima JJ; McFarland DA; Khoromana CO; Campbell CC
    Trans R Soc Trop Med Hyg; 1990; 84(4):496-8. PubMed ID: 2091336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of drugs for malaria control in tropical Africa.
    Kouznetsov R
    Bull World Health Organ; 1979; 57(4):535-9. PubMed ID: 316734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The OCCGE (Organisation de Coordination et de Coopération pour la Lutte contre les Grandes Endémies) and the surveillance of the drug sensitivity of Plasmodium falciparum to antimalarials].
    Gbary AR; Guiguemde TR; Ouedraogo JB; Baudon D; Douchet CJ; Le Bras J; Breman J
    Bull Soc Pathol Exot Filiales; 1987; 80(3 Pt 2):461-8. PubMed ID: 3319256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens.
    Zucker JR; Lackritz EM; Ruebush TK; Hightower AW; Adungosi JE; Were JB; Metchock B; Patrick E; Campbell CC
    Am J Trop Med Hyg; 1996 Dec; 55(6):655-60. PubMed ID: 9025694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malaria prevention in travellers from the United Kingdom. Report of meetings convened by the Ross Institute.
    Br Med J (Clin Res Ed); 1981 Jul; 283(6285):214-8. PubMed ID: 6789972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of chemotherapy in malaria control through primary health care: constraints and future prospects.
    Jeffery GM
    Bull World Health Organ; 1984; 62 Suppl(Suppl):49-53. PubMed ID: 6335682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combating malaria in Africa.
    Trape JF; Pison G; Spiegel A; Enel C; Rogier C
    Trends Parasitol; 2002 May; 18(5):224-30. PubMed ID: 11983604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.